Back to search results

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

Abroad (travel likely)Recruiting

Conditions

Type 1 Diabetes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Hoag Memorial Hospital, Newport Beach, California, United States

    Contact: Study coordinator (Brittany Dennis) · Brittany.Dennis@hoag.org · 949-764-6896
    Contact: Principal Investigator (David Ahn, MD)

  • Emory University, Atlanta, Georgia, United States

    Contact: Study coordinator (sabeena usman) · sabeena.usman@emory.edu · 404-251-8959
    Contact: Principal Investigator (Francisco Pasquel, MD)

  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Evelyn Fronczyk) · evelyn.guevara@northwestern.edu · 312-908-9002
    Contact: Principal Investigator (Grazia Aleppo, MD)

  • Maine Health Research Institute, Portland, Maine, United States

    Contact: Study coordinator (Debra Burris) · debra.burris@mainehealth.org · 207-662-2467
    Contact: Principal Investigator (Jay Ambalavanan, MD)

  • Harvard Medical School, Boston, Massachusetts, United States

    Contact: Study coordinator (Grace Ordonez) · gordonez@bwh.harvard.edu · 617-732-4245
    Contact: Principal Investigator (Zeb Saeed, MD)

  • Henry Ford Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Lydia Oehring) · loehrin1@hfhs.org · 313-916-3906
    Contact: Principal Investigator (Davida Kruger, ANP)

  • Mount Sinai, New York, New York, United States

    Contact: Study coordinator (Sophie Baun) · sophie.baum@mssm.edu · 212-241-4301
    Contact: Principal Investigator (Carol Levy, MD)
View source on ClinicalTrials.gov(opens in a new tab)